Biliary tract cancers (BTCs) include cholangiocarcinoma (intrahepatic, perihilar and extrahepatic), carcinoma of the gall bladder and ampullary carcinoma. In patients with advanced disease the ...

The treatment is indicated for patients with locally advanced biliary tract cancer which cannot be surgically resected or has metastasised. Durvalumab is the first immunotherapy to be offered as ...

MSD’s PD-1 inhibitor Keytruda has been approved by the FDA as a treatment for locally advanced unresectable or metastatic biliary tract cancer (BTC) in combination with chemotherapy, the first ...

Bevacizumab in combination with atezolizumab and chemotherapy led to improvements in progression-free survival and duration ...

Three of the total 103 research projects on the list involve researchers at KI: AI for early detection and prognosis of ...

H.C. Wainwright analyst Joseph Pantginis says Leerink this morning downgraded Compass Therapeutics (CMPX) saying the company’s biliary ...

Several of these same peptides could also distinguish BTC from benign cases of biliary disease albeit with lower accuracy, though none were discriminatory when using a smaller subset of 10 samples ...

Eisai has filed for approval in Japan for tasurgratinib, its small-molecule fibroblast growth factor (FGF) receptor inhibitor, as a treatment for biliary tract cancers with FGFR2 gene fusion ...

This trial was done to find out if oxaliplatin and 5FU is useful for people with advanced biliary tract cancer who have already had chemotherapy. Read more about A trial looking at oxaliplatin and 5FU ...

Akeso begins patient enrollment in phase 3 trial of ivonescimab combination as first-line therapy for biliary tract tumours, compared to durvalumab: China Monday, November 4, 2024 ...

Fully enrolled the Phase 2/3 trial of lead asset CTX-009 (DLL4 and VEGF-A bispecific antibody) in patients with biliary tract cancers (BTC); ...